Pathways upregulated in the KRAS/TP53-mut group were associated with vital physiological functions, while pathways downregulated in the KRAS/TP53-mut group were enriched in metabolism, indicating the presence of metabolic disorders in the group. The gene discussed is KRAS; the disease is metabolic disease.